Jump to content

MPM (psychedelic)

From Wikipedia, the free encyclopedia
MPM
Names
Preferred IUPAC name
1-(2,5-Dimethoxy-4-propoxyphenyl)propan-2-amine
Other names
2,5-Dimethoxy-4-propoxyamphetamine; 2,5-Dimethoxy-α-methyl-4-propoxybenzeneethanamine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C14H23NO3/c1-5-6-18-14-8-11(7-10(2)15)12(16-3)9-13(14)17-4/h8-10H,5-7,15H2,1-4H3 checkY
    Key: FTJOFRCENIVFLC-UHFFFAOYSA-N checkY
  • InChI=1/C14H23NO3/c1-5-6-18-14-8-11(7-10(2)15)12(16-3)9-13(14)17-4/h8-10H,5-7,15H2,1-4H3
    Key: FTJOFRCENIVFLC-UHFFFAOYAE
  • COc1cc(OC)c(cc1OCCC)CC(C)N
Properties
C14H23NO3
Molar mass 253.342 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

MPM (2,5-dimethoxy-4-propoxyamphetamine) is a lesser-known psychedelic drug and a substituted amphetamine.

MPM was first synthesized by Alexander Shulgin. In his book PiHKAL, dosage is given as "30 mg or more" and duration "probably short".[1] MPM is of low potency and produced only slight effects at the highest dose reported in PiHKAL of 30 mg, although its effects at higher doses than this have not been reported.

Very little data exists about the pharmacological properties, metabolism, and toxicity of MPM.

See also

[edit]

References

[edit]